SCHEMBL25679796

SCHEMBL25679796

Cc1cc(CCc2ccccc2)cc(Br)n1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
KCNH2 Q12809 2/20 0.42
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
GRM5 P41594 1/20 0.38
ATP4A P20648 1/20 0.38
ATP4B P51164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8194463 0.86 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDKCNH2HTT
SCHEMBL25679799 0.85 CALM1 (0.44) ALDH1A1ADORA2AADORA1HTTL3MBTL1
SCHEMBL9356136 0.81 KCNH2 (0.47) ALDH1A1KDM4EHPGDKCNH2L3MBTL1
SCHEMBL25679800 0.81 TSHR (0.50) ALDH1A1KDM4EADORA2AADORA1HTT
SCHEMBL25928587 0.77 HPGD (0.41) HPGDKCNH2TDP1
SCHEMBL24156678 0.76 RAB9A (0.46) HPGDHTTL3MBTL1NOS2
SCHEMBL29222897 0.76 KCNH2 (0.53) ALDH1A1KDM4EHPGDKCNH2TDP1
SCHEMBL25946165 0.75 HPGD (0.42) ALDH1A1KDM4EHPGDKCNH2L3MBTL1
SCHEMBL26608275 0.73 MAOB (0.50) ALDH1A1HTTL3MBTL1
SCHEMBL568443 0.72 ACHE (0.36) ALDH1A1KDM4EADORA2AADORA1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed